We have a friendly team of representatives across the world who are ready to help you. If you would like more information on our products and services, please contact us.
Properties of an ideal haemostat?
- Achieves haemostasis
- Reduces delayed bleeds
- Maintains visibility during the procedure
- Reaches narrow areas where clips/cautery are not sufficient
Properties of an ideal haemostat?
- Achieves haemostasis
- Ready to use immediately
- Maintains visibility during the procedure
- Doesn’t clog the applicator over time
Properties of an ideal haemostat?
- Achieves haemostasis
- Maintains visibility during the procedure
- Reaches uneven and narrow spaces
- An alternative to nasal packing
Benefits of PuraStat
Examples of clinical areas it is suitable for:
- Resections
- Upper and lower GI bleeds
- Radiation proctopathy
Benefits of PuraStat / PuraBond2
- No preparation required
- Transparent
- Achieves haemostasis in seconds3
Examples of clinical areas it is suitable for:
- Aortic surgery
- Coronary artery bypass graft
- Valve replacement/repair
Benefits of PuraBond
- Transparent
- Flexible, slightly viscous gel
- Stays on resected site for up to 6 days4
Examples of clinical areas it is suitable for:
- Rhinology
- Head and neck
- Cosmetic procedures including rhinoplasty
Advanced Peptide Technology
Our products are made up of synthetic peptides which self-assemble upon contact with physiological fluids, creating a specific three-dimensional shape that mimics the mammalian extracellular matrix. This unique matrix is what makes our product stand out against the other haemostatic agents in the market.
Discover More
Data backed and driven solutions
All of our products have been tested and approved in both clinical and laboratory settings. We are constantly working with leading Healthcare Professionals to ensure that our solutions are meeting their needs, and the data speaks for itself.
Check it Out
Global, Agile and Local
Since the inceptions of 3-D Matrix as a spinoff from MIT in 2004, 3-D Matrix has grown to become leading global peptide solutions company headquartered in Tokyo, Japan. With offices serving the Americas, Europe and Asia our employees together with our partners and distributor serve research scientists, healthcare providers and patients around the globe.
Learn More
*after colonic ESD
1. PuraStat IFU-007 Rev 2
2. PuraBond IFU-009 Rev 2
3. Moshuis M, Final Clinical Study Report: A Single Centre, Single Arm Post -Market Clinical Follow Up to
Confirm the Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding After Left Ventricular Assist Device (LVAD) Implantation, BR CV 003 EU EN v1 2019 09 13
4. Tsiamoulos. Z, Rajaratnam. R,Sibbons. P, Saunders, B. May 2017. Mo1994 Use of a Novel Synthetic, Topical Gel to Enhance Healing Post Endoscopic Mucosal Resection: A Randomised, Blinded Preclinical Study. Gastrointestinal Endoscopy, Vol. 85, Issue 5.
